Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q1 2021 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2021-05-17

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value: $835M (100.0% shares, 0.0% debt)

Holdings (13)

— Kinnate Biopharma Inc. 36.1%

Value $301M Shares 9,671,643 Est. Cost $39.78 Unrealized —

PHVS Pharvaris N.V. 10.9%

Value $91.27M Shares 3,261,926 Est. Cost $31.46 Unrealized 0.0%

ACRS Aclaris Therapeutics, Inc. 10.3%

Value $85.66M Shares 3,399,034 Est. Cost $15.18 Unrealized +28.8%

KROS Keros Therapeutics, Inc. 10.2%

Value $85.1M Shares 1,382,641 Est. Cost $30.81 Unrealized +105.6%

RLAY Relay Therapeutics, Inc. 8.9%

Value $73.96M Shares 2,139,380 Est. Cost $38.13 Unrealized +13.8%

ALXO ALX Oncology Holdings Inc. 6.9%

Value $57.96M Shares 785,945 Est. Cost $39.31 Unrealized +100.2%

KURA Kura Oncology, Inc. 6.3%

Value $52.3M Shares 1,849,947 Est. Cost $20.39 Unrealized +55.2%

NRIX Nurix Therapeutics, Inc. 4.6%

Value $38.5M Shares 1,238,456 Est. Cost $25.20 Unrealized +50.1%

CYTK Cytokinetics Incorporated 2.5%

Value $20.51M Shares 881,901 Est. Cost $8.72 Unrealized +144.9%

OLMA Olema Pharmaceuticals, Inc. 1.6%

Value $13.04M Shares 393,030 Est. Cost $46.89 Unrealized -8.6%

— Cymabay Therapeutics, Inc. 1.0%

Value $8.113M Shares 1,787,094 Est. Cost $3.49 Unrealized —

— Therapeutics Acquisition Corp 0.4%

Value $3.679M Shares 350,000 Est. Cost $14.38 Unrealized —

— Decibel Therapeutics, Inc. 0.4%

Value $3.382M Shares 297,711 Est. Cost $11.36 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Kinnate Biopharma Inc.	9,671,643	$301M	36.1%	$39.78	—	COM	49705R105
PHVS	Pharvaris N.V.	3,261,926	$91.27M	10.9%	$31.46	0.0%	COM	N69605108
ACRS	Aclaris Therapeutics, Inc.	3,399,034	$85.66M	10.3%	$15.18	+28.8%	COM	00461U105
KROS	Keros Therapeutics, Inc.	1,382,641	$85.1M	10.2%	$30.81	+105.6%	COM	492327101
RLAY	Relay Therapeutics, Inc.	2,139,380	$73.96M	8.9%	$38.13	+13.8%	COM	75943R102
ALXO	ALX Oncology Holdings Inc.	785,945	$57.96M	6.9%	$39.31	+100.2%	COM	00166B105
KURA	Kura Oncology, Inc.	1,849,947	$52.3M	6.3%	$20.39	+55.2%	COM	50127T109
NRIX	Nurix Therapeutics, Inc.	1,238,456	$38.5M	4.6%	$25.20	+50.1%	COM	67080M103
CYTK	Cytokinetics Incorporated	881,901	$20.51M	2.5%	$8.72	+144.9%	COM	23282W605
OLMA	Olema Pharmaceuticals, Inc.	393,030	$13.04M	1.6%	$46.89	-8.6%	COM	68062P106
—	Cymabay Therapeutics, Inc.	1,787,094	$8.113M	1.0%	$3.49	—	COM	23257D103
—	Therapeutics Acquisition Corp	350,000	$3.679M	0.4%	$14.38	—	COM CL A	88339T103
—	Decibel Therapeutics, Inc.	297,711	$3.382M	0.4%	$11.36	—	COM	24343R106